African trypanosomiasis epidemiology and demographics

Jump to navigation Jump to search

African trypanosomiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating African trypanosomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

African trypanosomiasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of African trypanosomiasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on African trypanosomiasis epidemiology and demographics

CDC on African trypanosomiasis epidemiology and demographics

African trypanosomiasis epidemiology and demographics in the news

Blogs on African trypanosomiasis epidemiology and demographics

Directions to Hospitals Treating African trypanosomiasis

Risk calculators and risk factors for African trypanosomiasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Pilar Almonacid , Aditya Ganti M.B.B.S. [2]

Overview

Currently, it is estimated that the annual prevalance of African trypanosomiasis is less than 20,000. In 2014, 3,796 sleeping sickness cases were reported to the World Health Organization and T. b. gambiense accounted for >98% of cases. There is no age predominance for African trypanosomiasis disease.[1][2][3][4]

Epidemiology

Incidence and prevalance

  • The global incidence of African trypanosomiasis is estimated to be 7,000-10,000.
  • In 2014, 3,796 sleeping sickness cases were reported to the World Health Organization; T. b. gambiense accounted for >98% of cases.
  • Currently, it is estimated that the annual prevalance of African trypanosomiasis is less than 20,000.

Demographics

Age

  • There is no age predominance for African trypanosomiasis disease.[1][2][3][4]
  • The rate of African trypanosomiasis is high among neonates due to risk of vertical transmission during pregnancy.

Gender

  • Men and women are affected equally by African trypanosomiasis.
  • Male gender is thought to be associated with worse prognosis than female gender.

Race

  • Given the endemicity of the disease in South America, the majority of individuals with African trypanosomiasis are of Hispanic origin.
  • However, there is no evidence to demonstrate that there is any racial predilection to the acquisition of the infection.

Geographic distrubution

  • African trypanosomiasis is endemic in rural sub-Saharan Africa.
  • T. b. rhodesiense is found in eastern and southeastern Africa, mainly Tanzania, Uganda, Malawi, Zambia, and Zimbabwe.
  • T. b. gambiense is found in central Africa and in limited areas of West Africa, primarily in Democratic Republic of the Congo, Central African Republic, Angola, South Sudan, Guinea, Cameroon, Gabon, Côte d’Ivoire, Congo, Chad, and northern Uganda.

References

  1. 1.0 1.1 Fèvre EM, Picozzi K, Jannin J, Welburn SC, Maudlin I (2006). "Human African trypanosomiasis: Epidemiology and control". Adv. Parasitol. 61: 167–221. doi:10.1016/S0065-308X(05)61005-6. PMID 16735165.
  2. 2.0 2.1 Franco JR, Simarro PP, Diarra A, Jannin JG (2014). "Epidemiology of human African trypanosomiasis". Clin Epidemiol. 6: 257–75. doi:10.2147/CLEP.S39728. PMC 4130665. PMID 25125985.
  3. 3.0 3.1 "Trypanosomiasis, African (Sleeping Sickness) - Chapter 3 - 2018 Yellow Book | Travelers' Health | CDC".
  4. 4.0 4.1 "WHO | The current situation".